主營(yíng)產(chǎn)品:雜質(zhì)對(duì)照品,標(biāo)準(zhǔn)品
客服熱線:13165688766
4YR企業(yè)會(huì)員
英文名稱(chēng) | 中文名稱(chēng) | CAS號(hào) | 操作 |
Trimethoprim EP Impurity I (E-Isomer) | 甲氧芐啶EP雜質(zhì)I | 118791-61-0 | 詳細(xì) |
Allopurinol Impurity 1 | 別嘌醇雜質(zhì)H | 41621-10-7 | 詳細(xì) |
Allopurinol Impurity 2 | 6-甲基-1氫-吡唑并[3,4-D]嘧啶-4(5H氫)酮 | 30129-57-8 | 詳細(xì) |
Metronidazole EP Impurity C | 甲硝唑雜質(zhì)C | 5006-69-9 | 詳細(xì) |
Metronidazole EP Impurity E | 異甲硝唑 | 705-19-1 | 詳細(xì) |
Metronidazole EP Impurity F | O-羥乙基甲硝唑 | 16156-94-8 | 詳細(xì) |
Azilsartan Impurity 25 | 阿齊沙坦雜質(zhì)5 | 183986-69-8 | 詳細(xì) |
Azilsartan Impurity 26 | 阿齊沙坦雜質(zhì) 10 | 139481-40-6 | 詳細(xì) |
Azilsartan Impurity 27 | 1-[(2'-(羥基脒基)[1,1-聯(lián)苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯 | 147403-65-4 | 詳細(xì) |
Azilsartan Impurity 29 | 147404-12-4 | 詳細(xì) | |
Azilsartan Impurity 30 | 阿齊沙坦雜質(zhì)N | 2244031-86-3 | 詳細(xì) |
Azilsartan Impurity 31 | 美阿沙坦鉀雜質(zhì)8 | 1993494-84-0 | 詳細(xì) |
Azilsartan Impurity 36 | 1-[(2'-氰基聯(lián)苯-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯 | 139481-44-0 | 詳細(xì) |
Azilsartan Impurity 40 | 阿齊沙坦雜質(zhì)15 | 147403-35-8 | 詳細(xì) |
Glimepiride Impurity 1 | 格列美脲雜質(zhì)6 | 247098-17-5 | 詳細(xì) |
Sorafenib EP Impurity A | 4-(4-氨基苯氧基)-N-甲基-2-吡啶甲酰胺 | 284462-37-9 | 詳細(xì) |
Sorafenib EP Impurity D | Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | 2206827-14-5 | 詳細(xì) |
Oseltamivir impurity 39 | 奧司他韋雜質(zhì)B(2-疊氮雜質(zhì)) | 2125702-80-7 | 詳細(xì) |
Oseltamivir impurity 41 | (1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | 2413185-89-2 | 詳細(xì) |
Oseltamivir impurity 43 | 奧司他韋雜質(zhì)17 | 2413185-88-1 | 詳細(xì) |
Oseltamivir impurity 49 | (3R,4S,5R)-4,5-二羥基-3-(戊烷-3-羥基)環(huán)己-1-烯-1-羧酸乙酯 | 2097777-49-4 | 詳細(xì) |
Oseltamivir impurity 52 | 28547-24-2 | 詳細(xì) | |
Oseltamivir impurity 53 | 1070663-96-5 | 詳細(xì) | |
Olaparib Impurity 3 | (3-氧代-1,3-二氫異苯并呋喃-1-基)膦酸二甲酯 | 61260-15-9 | 詳細(xì) |
Olaparib Impurity 4 | 5-[(3.4-二氫-4-氧代-1-酞嗪基)甲基]-2-氟苯腈 | 1021298-68-9 | 詳細(xì) |
Olaparib Impurity 6 | 2-氟-5-溴苯腈 | 179897-89-3 | 詳細(xì) |
Olaparib Impurity 7 | N-BOC-哌嗪 | 57260-71-6 | 詳細(xì) |
Olaparib Impurity 8 | 環(huán)丙甲酸 | 1759-53-1 | 詳細(xì) |
Olaparib Impurity 10 | 哌嗪二鹽酸鹽 | 142-64-3 | 詳細(xì) |
Olaparib Impurity 15 | 1,1,3,3-四甲基脲 | 632-22-4 | 詳細(xì) |
Butylphthalide Impurity 3 | 1(3H)-Isobenzofuranone, 5-bromo-3-hydroxy- | 102126-71-6 | 詳細(xì) |
Butylphthalide Impurity 4 | 丁苯酞雜質(zhì)18 | 503822-00-2 | 詳細(xì) |
Butylphthalide Impurity 5 | 6-溴-3-羥基異苯并呋喃-1(3氫)-酮 | 1225206-60-9 | 詳細(xì) |
Butylphthalide Impurity 6 | 丁苯酞雜質(zhì)27 | 1225206-61-0 | 詳細(xì) |
Butylphthalide Impurity 7 | 3,6-二溴異苯并呋喃-1(3H)-酮 | 40125-50-6 | 詳細(xì) |
Butylphthalide Impurity 8 | 3,5-DIBROMO-1,3-DIHYDRO-2-BENZOFURAN-1-ONE | 102126-70-5 | 詳細(xì) |
Butylphthalide Impurity 9 | 3-butyl-5-bromo-1(3H)-isobenzofuranone | 950681-35-3 | 詳細(xì) |
Phloroglucinol Impurity 1 | 2,4,6-三甲氧基甲苯 | 14107-97-2 | 詳細(xì) |
Phloroglucinol Impurity 72 | Benzene, 1,3,5-trimethoxy-2-(methylthio)- | 154389-62-5 | 詳細(xì) |
Phloroglucinol Impurity 73 | 2,4,6,3',5'-PENTAMETHOXYBIPHENYL | 84212-55-5 | 詳細(xì) |
Valsartan Impurity 5 | 纈沙坦雜質(zhì)Ⅱ | 1111177-30-0 | 詳細(xì) |
Nedaplatin impurity 3 | 奈達(dá)鉑雜質(zhì)5 | 103436-60-8 | 詳細(xì) |
Mesalazine EP Impurity S | 美沙拉嗪EP雜質(zhì)S | 1797983-23-3 | 詳細(xì) |
Tryptophan EP Impurity A | 粉色E | 132685-02-0 | 詳細(xì) |
Tryptophan EP Impurity B | 色氨酸雜質(zhì)B(非對(duì)映體的混合物) | 184955-21-3 | 詳細(xì) |
Tryptophan EP Impurity C | L-犬尿氨酸 | 2922-83-0 | 詳細(xì) |
Tryptophan EP Impurity D | 5-羥基-L-色氨酸 | 4350-09-8 | 詳細(xì) |
Tryptophan EP Impurity E | N'-甲酰基-L-尿嘧啶 | 3978-11-8 | 詳細(xì) |
Tryptophan EP Impurity F | 色氨酸雜質(zhì) | 145545-23-9 | 詳細(xì) |
Tryptophan EP Impurity H | 2,3,4,9-四氫-1H-beta-咔啉-3-甲酸 | 6052-68-2 | 詳細(xì) |
Tryptophan EP Impurity I | 1 - 甲基-2,3,4,9 - 四氫-1H-Β-咔啉-3 - 羧酸鹽DATA | 5470-37-1 | 詳細(xì) |
Tryptophan EP Impurity J | Tryptophan Impurity 3 | 164068-19-3 | 詳細(xì) |
Tryptophan EP Impurity K | L-色氨酸EP雜質(zhì)K | 149724-31-2 | 詳細(xì) |
Tryptophan EP Impurity L | 色氨酸EP雜質(zhì)E | 287170-99-4 | 詳細(xì) |
Tryptophan Impurity 1 | 色氨酸EP雜質(zhì)G | 236094-74-9 | 詳細(xì) |
Tryptophan Impurity 2 | DL-2,3-二氫-2-氧雜色氨酸 | 32999-55-6 | 詳細(xì) |
Tofacitinib Impurity 17 | 托法替尼雜質(zhì) | 2459302-77-1 | 詳細(xì) |
Tofacitinib Impurity 22 | Tofacitinib Impurity 29 | 1638499-35-0 | 詳細(xì) |
Tofacitinib Impurity 23 | 托法替尼雜質(zhì)166 | 1638499-36-1 | 詳細(xì) |
Afatinib Impurity 4 | N-(3-氯-4-氟苯基)-7-甲氧基-6-硝基喹唑啉-4-胺 | 179552-74-0 | 詳細(xì) |
Afatinib Impurity 5 | Afatinib Impurity JXH | 2223677-60-7 | 詳細(xì) |
Afatinib Impurity 6 | 阿法替尼雜質(zhì)18 | 2413212-25-4 | 詳細(xì) |
Afatinib Impurity 7 | 4-氯-7-氟-6-硝基喹唑啉 | 162012-70-6 | 詳細(xì) |
Afatinib Impurity 9 | 阿法替尼中間體 | 314771-88-5 | 詳細(xì) |
Afatinib Impurity 11 | P-[2-[[4-[(3-氯-4-氟苯基)氨基]-7-[[(3S)-四氫-3-呋喃基]氧基-6-喹唑啉基]氨基]-2-氧代乙基]膦酸二乙酯 | 618061-76-0 | 詳細(xì) |
Afatinib Impurity 13 | 4-Hydroxy 4-Dedimethylamino Afatinib | 2121530-37-6 | 詳細(xì) |
Afatinib Impurity 14 | Afatinib IMpurity SF | 2223677-62-9 | 詳細(xì) |
Afatinib Impurity 15 | Afatinib IMpurity SCl | 2223677-63-0 | 詳細(xì) |
Afatinib Impurity 27 | (S)-N1-(4-((3-氯-4-氟苯基)氨基)-7-(((四氫呋喃-3-基)氧基)喹唑啉-6-基)-N2,N2-二甲基草酰胺(阿法替尼雜質(zhì)) | 2223677-66-3 | 詳細(xì) |
Afatinib Impurity 28 | 阿法替尼雜質(zhì)DES-EJA | 2223677-64-1 | 詳細(xì) |
Afatinib Impurity 29 | 阿法替尼雜質(zhì)I | 1637254-93-3 | 詳細(xì) |
Afatinib Impurity 30 | N-(3-氯-4-氟苯基)-7-乙氧基-6-硝基-4-喹唑啉胺 | 1360430-70-1 | 詳細(xì) |
Afatinib Impurity 31 | Afatinib Impurity 6 | 2413212-07-2 | 詳細(xì) |
Nedaplatin impurity 2 | 奈達(dá)鉑雜質(zhì)4 | 20115-64-4 | 詳細(xì) |
Doxofylline Impurity 13 | 茶堿雜質(zhì)23 | 23146-07-8 | 詳細(xì) |
Doxofylline Impurity 12 | 羥丙茶堿 | 603-00-9 | 詳細(xì) |
Doxofylline Impurity 10 | 多索茶堿雜質(zhì)02 | 180262-60-6 | 詳細(xì) |
Doxofylline Impurity 7 | 多索茶堿雜質(zhì)7 | 詳細(xì) | |
Diclofenac EP Impurity E | 2-吲哚酮 | 59-48-3 | 詳細(xì) |
Erythromycin EP Impurity M | Erythromycin EP Impurity M | 616234-56-1 | 詳細(xì) |
Olaparib Impurity 23 | 3-羥基異苯并呋喃-1(3H)-酮 | 16859-59-9 | 詳細(xì) |
Afatinib Impurity 32 | 馬來(lái)酸阿法替尼雜質(zhì)雜質(zhì)SM1-8-1 | 1269662-90-9 | 詳細(xì) |
Afatinib Impurity 24 | (S,E)-N-(4-((4-氯-3-氟苯基)氨基)-7-((四氫呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲基氨基)但是- 2-烯酰胺 (阿法替尼雜質(zhì)) | 2475094-87-0 | 詳細(xì) |
Paliperidone Impurity 4 | 5-氟-3-(4-哌啶基)-1,2-苯并異噁唑鹽酸鹽 | 84163-64-4 | 詳細(xì) |
Azilsartan Medoxomil | 阿奇沙坦酯 | 863031-21-4 | 詳細(xì) |
Azilsartan Impurity 18 | 阿齊沙坦雜質(zhì) (F) | 147404-75-9 | 詳細(xì) |
Afatinib Impurity 22 | Afatinib impurity 9 | 2170273-17-1 | 詳細(xì) |
Afatinib Impurity 23 | 7-[(R)-(四氫呋喃-3-基)氧基]-N-(3-氯-4-氟苯基)-6-氨基-4-氨基喹唑啉 | 402855-03-2 | 詳細(xì) |
Brexpiprazole Impurity 16 | 7-(4-氯丁氧基)-2(1H)-喹啉酮 | 913613-82-8 | 詳細(xì) |
Olaparib Impurity 19 | 奧拉帕利雜質(zhì)31 | 458535-34-7 | 詳細(xì) |
Butylphthalide Impurity 1 | 2-戊?;郊姿?/td> | 550-37-8 | 詳細(xì) |
Azilsartan Impurity 19 | 坎地沙坦酯中間體 | 139481-41-7 | 詳細(xì) |
Azilsartan Impurity 21 | 阿齊沙坦雜質(zhì) | 632322-61-3 | 詳細(xì) |
Hydroxybupropion | 羥基安非他酮 | 92264-81-8 | 詳細(xì) |
Afatinib Impurity 18 | 2-氨基-4-氟苯甲酸 | 446-32-2 | 詳細(xì) |
Afatinib Impurity 20 | Afatinib IMpurity J | 1456696-14-2 | 詳細(xì) |
Afatinib Impurity 26 | 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(methylamino)-, (2E)- | 2413212-13-0 | 詳細(xì) |
Azilsartan Medoxomil Potassium Salt | 阿齊沙坦酯衍生物 | 863031-24-7 | 詳細(xì) |
Butylphthalide Impurity 2 | 丁苯酞雜質(zhì) | 199736-94-2 | 詳細(xì) |
Brexpiprazole Impurity 12 | 依匹哌唑雜質(zhì)06 | 2137823-20-0 | 詳細(xì) |
產(chǎn)品總數(shù):3001 產(chǎn)品頁(yè)碼: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 |
商家暫時(shí)不對(duì)外公布